SABBY MANAGEMENT, LLC
Regulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
Schedule 13D/13G stakes
Stakes of 5% or more disclosed on Schedule 13D or 13G, each on the filer's latest filing for the security. These are event-dated stakes, not the quarter-end 13F portfolio below.
| Company | Schedule | Event date | Filed | Shares | % of class | Status |
|---|---|---|---|---|---|---|
| BDRX Biodexa Pharmaceuticals Plc | 13G | Dec 31, 2025 | 10mo | 5,440 | 9.9% | Current |
| DSY Big Tree Cloud Holdings Ltd | 13G | Dec 31, 2025 | 10mo | 288,499 | 6.6% | Current |
| FOXO Foxo Technologies Inc. | 13G | Dec 31, 2025 | 10mo | 249,316,528 as filed | 9.9% | Current |
| GVH Globavend Holdings Ltd | 13G | Dec 31, 2025 | 10mo | 211,464 | 9.9% | Current |
| JZXN Jiuzi Holdings, Inc. | 13G/A | Dec 31, 2025 | 10mo | 206,273 | 9.9% | Current |
| MTRI InMed Pharmaceuticals Inc. | 13G | Dec 31, 2025 | 10mo | 28,014 | 9.9% | Current |
| NUWE Nuwellis, Inc. | 13G | Dec 31, 2025 | 10mo | 285 | 5.4% | Current |
| OGEN Oragenics Inc | 13G | Dec 31, 2025 | 10mo | 412,654 | 9.9% | Current |
| REVB Revelation Biosciences, Inc. | 13G | Dec 31, 2025 | 10mo | 21,632 | 9.6% | Current |
| TPST Tempest Therapeutics, Inc. | 13G | Dec 31, 2025 | 10mo | 492,223 | 9.9% | Current |
| TC Token Cat Ltd | 13G/A | Dec 31, 2024 | 1y | 7,338 | 5% | Current |
| MMEX MMEX Resources Corp | 13G | Dec 31, 2023 | 2y | 844,654,010 | 9.99% | Unconfirmed since Dec 31, 2023 |
A 13D or 13G stays in force until its filer amends it and no amendment is due without a material change, so a stake with no filing in 24 months reads unconfirmed, never sold. An amendment reporting under 5% ends the filer's duty to amend, not necessarily the holding. Shares are restated onto today's split basis. Show 24 exited, below-5% or retired stakes
Portfolio style
Measured from the filed 13F common-share book for Sep 30, 2026, never from the firm's own description.
Closest benchmark: every 13F filer's combined book, active share 96.0%; sector active share 47.6% against the combined 13F book's sector weights.
Over time 27 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+. Stocks and the top 10 weight count issuers: share classes of one company are one stock, and options are left out, so they can differ from the position count and top 10 concentration of GetInstitutionSummary and GetInstitutionPortfolio, which count each listed share class.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
14 common stock positions · as of Sep 30, 2026 · Δ vs Jun 30, 2026Portfolio Trend
Sector Breakdown
Common stock positions · as of Sep 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 52.0% | $3,481,073 |
| Healthcare | 34.4% | $2,303,075 |
| Unclassified | 4.2% | $277,890 |
| Consumer Cyclical | 3.9% | $260,624 |
| Basic Materials | 3.2% | $211,896 |
| Industrials | 2.3% | $155,488 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| REVB | Revelation Biosciences, Inc. | −83,667 | 126,915 | $103,689 | |
| BCTXL | BriaCell Therapeutics Corp. | −54,018 | 136,365 | $158,183 | |
| CRVO | CervoMed Inc. | −49,202 | 199,678 | $593,043 | |
| TOYO | TOYO Co., Ltd | −21,671 | 482,175 | $2,097,461 | |
| PAVS | Paranovus Entertainment Technology Ltd. | −10,769 | 64,671 | $260,624 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PN | PN Smart Energy Ltd | 269,000 | $737,060 | |
| YXT | YXT.COM GROUP HOLDING Ltd | 286,085 | $646,552 | |
| ZVRA | Zevra Therapeutics, Inc. | 57,850 | $634,614 | |
| APVO | Aptevo Therapeutics Inc. | 232,692 | $423,499 | |
| IWM | iShares Russell 2000 ETF | 1,000 | $277,890 | |
| CPHI | China Pharma Holdings, Inc. | 308,360 | $202,592 | |
| CANF | Can-Fite BioPharma Ltd. | 85,207 | $187,455 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| SPY | Spdr S&P 500 ETF Trust | 5,500 | $4,107,235 | |
| FAMI | Farmmi, Inc. | 3,515,929 | $843,822 | |
| TPST | Tempest Therapeutics, Inc. | 511,286 | $567,527 | |
| BIAF | bioAffinity Technologies, Inc. | 24,376 | $296,905 | |
| CREG | Smart Powerr Corp. | 127,774 | $263,214 | |
| BCTX | BriaCell Therapeutics Corp. | 80,721 | $261,536 | |
| MTRI | InMed Pharmaceuticals Inc. | 44,970 | $69,703 | |
| BCTXZ | BriaCell Therapeutics Corp. | 120,802 | $11,464 | |
| NUWE | Nuwellis, Inc. | 16,372 | $5,548 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| TOYO |
TOYO Co., Ltd
Technology
|
Reduced | 482,175 | $2,097,461 | 31.35% | |
| PN |
PN Smart Energy Ltd
Technology
|
NEW | 269,000 | $737,060 | 11.02% | |
| YXT |
YXT.COM GROUP HOLDING Ltd
Technology
|
NEW | 286,085 | $646,552 | 9.66% | |
| ZVRA |
Zevra Therapeutics, Inc.
Healthcare
|
NEW | 57,850 | $634,614 | 9.49% | |
| CRVO |
CervoMed Inc.
Healthcare
|
Reduced | 199,678 | $593,043 | 8.86% | |
| APVO |
Aptevo Therapeutics Inc.
Healthcare
|
NEW | 232,692 | $423,499 | 6.33% | |
| IWM |
iShares Russell 2000 ETF
|
NEW | 1,000 | $277,890 | 4.15% | |
| PAVS |
Paranovus Entertainment Technology Ltd.
Consumer Cyclical
|
Reduced | 64,671 | $260,624 | 3.90% | |
| SNES |
SenesTech, Inc.
Basic Materials
|
Added | 313,132 | $211,896 | 3.17% | |
| CPHI |
China Pharma Holdings, Inc.
Healthcare
|
NEW | 308,360 | $202,592 | 3.03% | |
| CANF |
Can-Fite BioPharma Ltd.
Healthcare
|
NEW | 85,207 | $187,455 | 2.80% | |
| BCTXL |
BriaCell Therapeutics Corp.
Healthcare
|
Reduced | 136,365 | $158,183 | 2.36% | |
| SIDU |
Sidus Space Inc.
Industrials
|
Added | 85,905 | $155,488 | 2.32% | |
| REVB |
Revelation Biosciences, Inc.
Healthcare
|
Reduced | 126,915 | $103,689 | 1.55% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.